Literature DB >> 8929787

Behcet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature.

K Yano1, K Eguchi, K Migita, H Takashima, M Tamura, K Izumino, I Sasagawa, N Sadamori, S Nagataki.   

Abstract

Two cases of Behcet's disease associated with myelodysplastic syndrome are described. Both patients showed a chromosomal abnormality, trisomy 8. Based on the laboratory findings in our patients and a careful review of the literature of similar cases, the association of the chromosomal abnormality with the pathogenesis of Behcet's disease is suggested.

Entities:  

Mesh：

Year:  1996        PMID： 8929787     DOI： 10.1007/bf02231696

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  11 in total

1.  In vivo leucocyte migration in Behçet's syndrome.

Authors:  J Efthimiou; I E Addison; B V Johnson
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

2.  [Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome].

Authors:  Y Chyuma; A Utsunomiya; T Saito; S Hanada; H Nishimata; T Arima
Journal:  Rinsho Ketsueki       Date:  1992-03

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 4.  [Incomplete-form of Behçet disease in a case of monopathic myelodysplastic syndrome presenting as a thrombocytopenia].

Authors:  Y Nehashi; Y Torii; M Yaguchi; Y Itoh; K Ohyashiki; K Toyama
Journal:  Rinsho Ketsueki       Date:  1988-07

5.  Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.

Authors:  Y Niwa; S Miyake; T Sakane; M Shingu; M Yokoyama
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

6.  Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia.

Authors:  A Yuo; S Kitagawa; T Okabe; A Urabe; Y Komatsu; S Itoh; F Takaku
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

7.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

Review 8.  Myelodysplastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia.

Authors:  J Stephenson; G J Mufti; Y Yoshida
Journal:  Int J Hematol       Date:  1993-04       Impact factor: 2.490

Review 9.  Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia.

Authors:  Y Yoshida; J Stephenson; G J Mufti
Journal:  Int J Hematol       Date:  1993-04       Impact factor: 2.490

10.  Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.

Authors:  F Solé; F Prieto; L Badia; S Woessner; L Florensa; M R Caballin; M D Coll; C Besses; J Sans-Sabrafen
Journal:  Cancer Genet Cytogenet       Date:  1992-11
View more
  4 in total

1.  Large-vessel thrombosis in intestinal Behçet's disease complicated with myelodysplastic syndrome and trisomy 8.

Authors:  Huang-Chi Chen; Ying-Ming Chiu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

2.  High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet's disease.

Authors:  Kosei Arimura; Naomichi Arima; Kakushi Matsushita; Masaki Akimoto; Chi Young Park; Kimiharu Uozumi; Chuwa Tei
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

3.  Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet disease.

Authors:  Kazumi Yamato
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

4.  Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.

Authors:  Hiroaki Tanaka; Naomi Shimizu; Emi Tougasaki; Chika Kawajiri; Shinichiro Hashimoto; Yusuke Takeda; Shio Sakai; Masahiro Takeuchi; Chikako Ohwada; Emiko Sakaida; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2013-03-22       Impact factor: 2.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.